Throughout Cartoon Network’s long history, the channel has been known to not just house cartoon classics, but also to create plenty of original series to fill out its roster. Even when the Warner Bros ...

Every fall, the leaves turn and flutter to the ground. Pumpkins are hollowed out and carved with the devilish grins of Jack-o'-lanterns; kids, young and old, dress up as ghosts, ghouls and goblins; ...

HBO Max has taken the axe to yet another beloved cartoon series. Just last week the Warner Bros. owned streaming service quietly removed more Cartoon Network shows from the platform. Courage the ...

Stephanie Brookes receives funding from the Australian Research Council. She is an Associate Member of the Australian Cartoonists' Association. Richard Scully receives funding from the Australian ...

Sign of the times: An AI agent autonomously wrote and published a personalized attack article against an open-source software maintainer after he rejected its code contribution. It might be the first ...

Feb 9 (Reuters) - A set of Catholic investors said on Monday private-prison operator GEO Group has rejected a shareholder vote designed to shed light on alleged human rights violations in its ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Top Food and Drug ...

The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has broadly rejected it, canceling millions of dollars in research projects. By ...

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday. The move is the latest sign that the FDA, under Health Secretary Robert F.

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by the FDA. In rejecting RGX-121, the FDA raised concerns about its clinical ...

Forbes contributors publish independent expert analyses and insights. Leslie Katz covers the intersection of culture, science and tech. This voice experience is generated by AI. Learn more. This voice ...